Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11230
Title: | Hepatitis a and e infection in international travellers. | Austin Authors: | Torresi, Joseph ;Johnson, Douglas F | Affiliation: | Infectious Diseases | Issue Date: | 1-Jun-2011 | Publication information: | Current Infectious Disease Reports; 13(3): 248-55 | Abstract: | Hepatitis A is the most common vaccine-preventable infection in travellers. The incidence of hepatitis A for travellers ranges from 3.0 to 11.0 per 100,000 person-months and the case-fatality rate is as high as 2 per 100,000 in non-immune travellers. Hepatitis A vaccine is highly effective in preventing infection, significantly reducing the incidence of hepatitis A in travellers, and an important preventative intervention for the "last-minute" traveller. Hepatitis E virus is an important cause of enterically transmitted hepatitis in developing countries. The overall risk of hepatitis E in travellers visiting endemic countries is relatively low compared to hepatitis A. The majority of cases have been reported from the Indian subcontinent. The case fatality rate for hepatitis E is 1.2%, although this is substantially higher in pregnant women. A vaccine for hepatitis E is not available, and therefore travellers must be made aware of preventative measures to reduce their risk of infection. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/11230 | DOI: | 10.1007/s11908-011-0179-7 | ORCID: | Journal: | Current Infectious Disease Reports | URL: | https://pubmed.ncbi.nlm.nih.gov/21424252 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
21424252.pdf | 55.68 kB | Adobe PDF | View/Open |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.